Relentless. Passionate. Focused.

Kiniksa Pharmaceuticals is a privately-held biotechnology company, focused on developing and delivering therapeutics for patients with debilitating diseases and high unmet medical needs. Kiniksa has a relentless, passionate and focused approach to drug development.

Our Story

Kiniksa has an experienced team who share a long and successful track record of delivering life-changing therapies to patients. We have numerous product-candidates in both clinical and preclinical development across a range of debilitating rare and specialty-focused indications with significant unmet need.

Our Strategy

Identify and rapidly develop product candidates with clear biology, validated mechanisms and the potential to deliver life-changing therapies to patients

PatientFocus

ClearBiology

Rare/SpecialtyDiseases

RapidDevelopment

GlobalVision

3

clinical stage molecules

1

planned pivotal study in a rare, debilitating disease

2

molecules in IND-enabling studies

+3

research stage molecules

>50

employees committed to helping patients